Jian Li

31PUBLICATIONS
60CO-AUTHORS
Molecular targetsAutoimmunityEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Sep 08, 2026
Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the m5C-HDAC8-CCL5 axis.

|Sep 04, 2026
Targeting the FOXP3-T-bet interaction to restore Treg stability in IFN-γ-driven autoimmunity.

|Apr 30, 2026
Regional characteristics of esophageal cancer and robot-assisted minimally invasive esophagectomy (RAMIE): an analysis of the international UGIRA registry.

|Mar 25, 2026
Conversion Surgery After Induction Therapy for Initially Unresectable Stage III Non-small Cell Lung Cancer: A Proof-of-Concept Trial.

Yan Yan, Yichao Han, Zhenyi Niu

|Feb 24, 2026
Specific depletion of TIGIThigh CD226- clonally expanded intratumoral Tregs defines safe and effective TIGIT targeting.

Haoyue Zhou, Jinmei Li, Song Mei

|Jan 27, 2026
Tumor neoantigen gene C7orf50 remodels the immune microenvironment by recruiting tumor-associated macrophages to promote hepatocellular carcinoma progression and lung metastasis.

Jia Li, Xinming Ye, Sheng Su

Pageof 6

Frequent Collaborators

5 joint publications

Bin Li

3 joint publications

Yichao Han

3 joint publications

Xuemei Tong

2 joint publications

Jianli He